The PDL1-PD1 Axis Converts Human T H 1 Cells into Regulatory T Cells
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The inhibitory ligand PDL1 transforms immune cells from attackers into regulators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
Robbins, P. F., Morgan, R. A., Feldman, S. A., Yang, J. C., Sherry, R. M., Dudley, M. E., Wunderlich, J. R., Nahvi, A. V., Helman, L. J., Mackall, C. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.2537 · Cited by 1,632
Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4 + T Cells
O’Shea, J. J., & Paul, W. E. (2010) · Science · doi:10.1126/science.1178334 · Cited by 1,336
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
Self-citationMolecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs
Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B., Chang, S. H., Schluns, K. S., Watowich, S. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.007 · Cited by 1,136
Late Developmental Plasticity in the T Helper 17 Lineage
Lee, Y. K., Turner, H., Maynard, C. L., Oliver, J. R., Chen, D., Elson, C. O., & Weaver, C. T. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.005 · Cited by 1,053
T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells
Afkarian, M., Sedy, J. R., Yang, J., Jacobson, N. G., Cereb, N., Yang, S. Y., Murphy, T. L., & Murphy, K. M. (2002) · Nature Immunology · doi:10.1038/ni794 · Cited by 1,037
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940 · cited 3×
“ScienceTr DISCUSSION CD4 T cells of the TH1 cytokine phenotype, which are essential to cell-mediated immunity against cancer and infectious disease, can be rendered ineffective bymultiple down-regulatory mechanisms including antigen-induced cell death (5), anergy due to cytokines suchasTGF-b (35) or due to surface mol…”
BackgroundFunction of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses
Lu, L.-F., Boldin, M. P., Chaudhry, A., Lin, L.-L., Taganov, K. D., Hanada, T., Yoshimura, A., Baltimore, D., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.08.012 · Cited by 849
Role of T-bet in Commitment of T H 1 Cells Before IL-12-Dependent Selection
Mullen, A. C., High, F. A., Hutchins, A. S., Lee, H. W., Villarino, A. V., Livingston, D. M., Kung, A. L., Cereb, N., Yao, T.-P., Yang, S. Y., et al. (2001) · Science · doi:10.1126/science.1059835 · Cited by 825
Ohigashi, Y., Sho, M., Yamada, Y., Tsurui, Y., Hamada, K., Ikeda, N., Mizuno, T., Yoriki, R., Kashizuka, H., Yane, K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1469 · Cited by 796
Sharma, M. D., Baban, B., Chandler, P., Hou, D.-Y., Singh, N., Yagita, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 792
T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells
Lighvani, A. A., Frucht, D. M., Jankovic, D., Yamane, H., Aliberti, J., Hissong, B. D., Nguyen, B. V., Gadina, M., Sher, A., Paul, W. E., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261570598 · Cited by 783
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2360 · Cited by 758
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells
Koenen, H. J. P. M., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. H., & Joosten, I. (2008) · Blood · doi:10.1182/blood-2008-01-133967 · Cited by 736
Bending, D., De La Peña, H., Veldhoen, M., Phillips, J. M., Uyttenhove, C., Stockinger, B., & Cooke, A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37865 · Cited by 558
Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning
Riley, J. L., June, C. H., & Blazar, B. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.006 · Cited by 412
Self-citationMartin‐Orozco, N., Chung, Y., Chang, S. H., Wang, Y., & Dong, C. (2009) · European Journal of Immunology · doi:10.1002/eji.200838475 · Cited by 359
Hegazy, A. N., Peine, M., Helmstetter, C., Panse, I., Fröhlich, A., Bergthaler, A., Flatz, L., Pinschewer, D. D., Radbruch, A., & Löhning, M. (2010) · Immunity · doi:10.1016/j.immuni.2009.12.004 · Cited by 340
Blazar, B. R., Carreno, B. M., Panoskaltsis-Mortari, A., Carter, L., Iwai, Y., Yagita, H., Nishimura, H., & Taylor, P. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1272 · Cited by 329
Franceschini, D., Paroli, M., Francavilla, V., Videtta, M., Morrone, S., Labbadia, G., Cerino, A., Mondelli, M. U., & Barnaba, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36604 · Cited by 318
Tatsumi, T., Kierstead, L. S., Ranieri, E., Gesualdo, L., Schena, F. P., Finke, J. H., Bukowski, R. M., Mueller-Berghaus, J., Kirkwood, J. M., Kwok, W. W., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012142 · Cited by 314
Ramsdell, F., Seaman, M. S., Miller, R. E., Picha, K. S., Kennedy, M. K., & Lynch, D. H. (1994) · International Immunology · doi:10.1093/intimm/6.10.1545 · Cited by 311
Sher, A., Fiorentino, D., Caspar, P., Pearce, E., & Mosmann, T. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2713 · Cited by 308
Chen, X., Das, R., Komorowski, R., Beres, A., Hessner, M. J., Mihara, M., & Drobyski, W. R. (2009) · Blood · doi:10.1182/blood-2009-01-197178 · Cited by 293
Schulz, E. G., Mariani, L., Radbruch, A., & Höfer, T. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.013 · Cited by 279
Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor
Chen, L., Sung, S.-S., Yip, M. L. R., Lawrence, H. R., Ren, Y., Guida, W. C., Sebti, S. M., Lawrence, N. J., & Wu, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025536 · Cited by 279
Mukasa, R., Balasubramani, A., Lee, Y. K., Whitley, S. K., Weaver, B. T., Shibata, Y., Crawford, G. E., Hatton, R. D., & Weaver, C. T. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.016 · Cited by 271
Kerkar, S. P., Muranski, P., Kaiser, A., Boni, A., Sanchez-Perez, L., Yu, Z., Palmer, D. C., Reger, R. N., Borman, Z. A., Zhang, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0735 · Cited by 254
Dissection of Signaling Cascades through gp130 In Vivo
Ohtani, T., Ishihara, K., Atsumi, T., Nishida, K., Kaneko, Y., Miyata, T., Itoh, S., Narimatsu, M., Maeda, H., Fukada, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80162-4 · Cited by 243
Mueller, S. N., Vanguri, V. K., Ha, S.-J., West, E. E., Keir, M. E., Glickman, J. N., Sharpe, A. H., & Ahmed, R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40040 · Cited by 160
Cutting Edge: The Th1 Response Inhibits the Generation of Peripheral Regulatory T Cells
Caretto, D., Katzman, S. D., Villarino, A. V., Gallo, E., & Abbas, A. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903412 · Cited by 115
Lee, I. T., Wang, L., Wells, A. D., Ye, Q., Han, R., Dorf, M. E., Kuziel, W. A., Rollins, B. J., Chen, L., & Hancock, W. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6929 · Cited by 115
Engineered Human tmpk/AZT As a Novel Enzyme/Prodrug Axis for Suicide Gene Therapy
Sato, T., Neschadim, A., Konrad, M., Fowler, D. H., Lavie, A., & Medin, J. A. (2007) · Molecular Therapy · doi:10.1038/mt.sj.6300122 · Cited by 103
Self-citationRegulatory T Cells and Human Myeloid Dendritic Cells Promote Tolerance via Programmed Death Ligand-1
Amarnath, S., Costanzo, C., Mariotti, J., Ullman, J. L., Telford, W., Kapoor, V., Riley, J., Levine, B., June, C., Fong, T., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000302 · Cited by 97
Self-citationYoshimitsu, M., Sato, T., Tao, K., Walia, J. S., Rasaiah, V. I., Sleep, G. T., Murray, G. J., Poeppl, A. G., Underwood, J. P., West, L. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407572101 · Cited by 89
Self-citationCheng, J., Ni, L., Zhang, Y., Zhang, C., Wu, X. Y., Atia, A. N., Thayer, P., Moorman, J. P., & Yao, Z. Q. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03382.x · Cited by 78
Nervi, B., Rettig, M. P., Ritchey, J., Wang, H. L., Bauer, G., Walker, J. E., Bonyhadi, M. L., BERENSON, R. J., Prior, J. L., Piwnica-Worms, D. R., et al. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.06.007 · Cited by 74
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer.
Kline, J. P., & Gajewski, T. F. (2010) · PubMed · Cited by 71
NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26)
Song, M.-N., Park, J. E., Park, S. G., Lee, D. H., Choi, H., Park, B. C., Ryu, S. E., Kim, J. H., & Cho, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.069 · Cited by 68
Holland, S. M. (2007) · Immunologic Research · doi:10.1007/s12026-007-0045-8 · Cited by 48
Li, X., Takiuchi, H., Zou, J., Katagiri, T., Yamamoto, N., Nagata, T., Ono, S., Fujiwara, H., & Hamaoka, T. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb02873.x · Cited by 45
Mariotti, J., Foley, J., Ryan, K. E., Buxhoeveden, N., Kapoor, V., Amarnath, S., & Fowler, D. H. (2008) · Blood · doi:10.1182/blood-2008-05-154278 · Cited by 44
Self-citationAmarnath, S., Flomerfelt, F. A., Costanzo, C. M., Foley, J., Mariotti, J., Konecki, D. M., Gangopadhyay, A., Eckhaus, M., Wong, S., Levine, B. L., et al. (2010) · Autophagy · doi:10.4161/auto.6.4.11811 · Cited by 42
Self-citation
Cited by
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
Chen, L., & Han, X. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80011 · Cited by 1,437
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.009 · Cited by 1,329
Vaddepally, R. K., Kharel, P., Pandey, R., Garje, R., & Chandra, A. B. (2020) · Cancers · doi:10.3390/cancers12030738 · Cited by 1,196
Rupp, L. J., Schumann, K., Roybal, K. T., Gate, R. E., Ye, C. J., Lim, W. A., & Marson, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-00462-8 · Cited by 757
Metadata
- Authors
- Amarnath, S., Mangus, C. W., Wang, J. C. M., Wei, F., He, A., Kapoor, V., Foley, J. E., Massey, P. R., Felizardo, T. C., Riley, J. L., Levine, B. L., June, C. H., Medin, J. A., & Fowler, D. H.
- Venue
- Science Translational Medicine
- Published
- 2011-11-30
- Volume
- 3
- Issue
- 111
- Pages
- 111ra120-111ra120
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2128395874
- Cited by
- 446
- References
- 50
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.